2012
DOI: 10.7175/cmi.v6i2.627
|View full text |Cite
|
Sign up to set email alerts
|

Meningococcal vaccine evolution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…The invasive meningococcal disease (IMD) from Neisseria meningitidis is still a frequently fatal pathology. The bacterium currently counts 13 recognized serogroups, among which A, B, C, W135, and Y are the most frequently isolated in the case of illness (1).…”
Section: Introductionmentioning
confidence: 99%
“…The invasive meningococcal disease (IMD) from Neisseria meningitidis is still a frequently fatal pathology. The bacterium currently counts 13 recognized serogroups, among which A, B, C, W135, and Y are the most frequently isolated in the case of illness (1).…”
Section: Introductionmentioning
confidence: 99%
“…Neisseria meningitidis is one of the main pathogens causing sporadic or outbreak cases of bacterial meningitis worldwide (Jafri et al , 2013). As a vaccine-preventable disease, meningococcal meningitis has changed dramatically in terms of incidence and prevalent serogroups, with the expanding application of vaccines against specific N. meningitidis serogroups (Bona & Guidi, 2012; Jafri et al , 2013; Zhou et al , 2012). In China, since a polysaccharide vaccine against serogroup A was included in the routine immunization program in 1984, the incidence of meningococcal meningitis has decreased to less than 0.2 %.…”
Section: Introductionmentioning
confidence: 99%
“…Patients with immune deficiency such as anatomic or functional asplenia or low levels or dysfunction of the terminal components of complement or properdin proteins have a higher risk of developing IMD [12][13][14][15][16][17][18][19]. Patients with late complement component deficiency (LCCD) usually develop the disease at an older age than the general population and are most often infected with uncommon serogroups Y or W135 [20][21][22].…”
Section: Introductionmentioning
confidence: 99%